<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 is the third highly pathogenic coronavirus that crossed the species barrier to cause fatal pneumonia in humans, after the SARS and MERS viruses causing the “severe acute respiratory syndrome” in 2002–2003 and the “Middle East respiratory syndrome” in 2012, respectively [
 <xref rid="B1-jcm-09-02084" ref-type="bibr">1</xref>]. It has been reported that the SARS-CoV pandemic potentially led to up to 8000 cases of infection with an approximately 10% fatality rate in the early 2000s, while MERS-CoV produced over 1700 cases and an approximately 36% fatality rate later on [
 <xref rid="B5-jcm-09-02084" ref-type="bibr">5</xref>]. Still, the recently discovered coronavirus elicits a greater rate of transmission, being already spread on all continents and encountering over 3,430,000 cases of infection up to the date of writing this article [
 <xref rid="B6-jcm-09-02084" ref-type="bibr">6</xref>]. Therefore, to date of writing this article, the number of confirmed COVID-19 patients worldwide [
 <xref rid="B7-jcm-09-02084" ref-type="bibr">7</xref>] was 3,435,894 with 239,604 reported deaths (
 <xref ref-type="fig" rid="jcm-09-02084-f001">Figure 1</xref>) [
 <xref rid="B8-jcm-09-02084" ref-type="bibr">8</xref>] and, based on the trends observed in the last days, these numbers might be underestimated in the upcoming period.
</p>
